Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1117-1126

  Fedson, David S ^a  

^a Pasteur Merieux Connaught   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ARTICLE; BELGIUM; CANADA; CONTROLLED STUDY; DEVELOPED COUNTRY; HUMAN; ICELAND; NORWAY; PRIORITY JOURNAL; REGISTRATION; REIMBURSEMENT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SWEDEN; UNITED KINGDOM; UNITED STATES; VACCINATION;

EID: 0031947404     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520272     Document Type: Article

References (23)

1. Fedson DS, Musher DM, Pneumococcal vaccine. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. 2nd ed. Philadelphia: WB Saunders, 1994:517-64.
2. Campbell JF, Donohue MA, Mochizuki RB, Nevin-Woods CL, Spika JS. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Hawaii Med J 1989;48:517-8.
3. Istre GR, Tarpay M, Anderson M, Pryor A, Welch D, the Pneumococcus Study Group. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis 1987;156:732-5.
4. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 1990;150:1401-5.
5. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992;82:1513-6.
6. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993;168:1532-6.
7. Hofman J, Cetron MS, Farley MM. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
8. Plouffe JF, Breiman RF, Facklam RR, for the Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA 1996;275:194-8.
9. Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in Southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996;174:752-9.
10. Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect 1996;117:411-6.
11. Hasseltvedt V, Hoiby EA, Iverson BG, Nokleby H. Systemisk Pneumokokksydom 1996. MSIS rapport 1997;25:8.
12. Raz R, Elhanan G, Shimoni Z, et al. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Clin Infect Dis 1997;24:1164-8.
13. McGeer A, Landry L, Goldenberg E, et al. Population-based surveillance for invasive pneumococcal infections in Toronto, Canada: implications for prevention [abstract]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1996:251.
14. Centers for Disease Control and Prevention. Pneumococcal polysaccharide vaccine. MMWR 1997;46(RR-8):1-24.
15. National Advisory Committee on Immunization. Canadian immunization guide. 4th ed. Ottawa: Health & Welfare Canada, 1993:92-4.
16. Fedson DS. Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other? Clin Infect Dis 1995;20:1371-6.
17. Fedson DS, Henrichsen J, Mäkelä PH, Austrian R, Immunization of elderly people with polyvalent pneumococcal vaccine. Infection 1989;17:437-41.
18. Fedson DS, Shapiro ED, LaForce FM, et al. Pneumococcal vaccine after 15 years of use: another view. Arch Intern Med 1994;154:2531-5.
19. Fedson DS, Hannoun C, Leese J, et al. Influenza vaccination in 18 developed countries, 1980-1992. Vaccine 1995;13:623-7.
20. Fedson DS, Hirota Y, Shin HK, et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine 1997;15:1506-11.
21. Division of Health Situation and Trend Assessment. Demographic data for health situation assessment and projections - 1996. Geneva: World Health Organization, 1996.
22. Joint Committee on Vaccination and Immunisation. Immunisation against infectious diseases. London: HMSO, 1992:100-3.
23. Peetermans W, Bachez P, Peleman R, et al. Belgian consensus on pneumococcal vaccine. Acta Clin Belg 1996;51:350-6.